Effets indésirables des traitements contre l’ostéoporose : comment les expliquer aux patient-e-s ? [Side effects of osteoporosis treatments: how to explain them to patients?]
Fiche du document
19 avril 2023
- doi: 10.53738/REVMED.2023.19.823.746
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.823.746
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37133954
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_0510C417447B3
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-10-19 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
TherapyCiter ce document
E. Curraj et al., « Effets indésirables des traitements contre l’ostéoporose : comment les expliquer aux patient-e-s ? [Side effects of osteoporosis treatments: how to explain them to patients?] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.823.746
Métriques
Partage / Export
Résumé
Despite the effectiveness of osteoporosis treatments, fear of side effects reduces both their prescription by doctors, and their acceptance by patients. The most common side effects are benign and transient, such as flu-like symptoms after zoledronate infusion, or nausea and dizziness after teriparatide introduction. On the other hand, the dreaded osteonecrosis of the jaw is very rare and associated with known risk factors. Only vertebral fractures after stopping denosumab make this treatment a matter for experienced practitioners. Therefore, knowing the side effects of prescribed treatments and explaining them to patients is essential to promote adherence.